1. Market Research
  2. > Biotechnology Market Trends
  3. > Biotechnology Analysis & Statistics in the United States, May 2015 (p107)

Biotechnology Analysis & Statistics in the United States, May 2015 (p107)

Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

All regions

3181-3210 of about 3300 reports

The US Molecular Diagnostic Testing Market 2015: Test Volume and Sales Forecasts by Application, and Supplier Shares by Test

The US Molecular Diagnostic Testing Market 2015: Test Volume and Sales Forecasts by Application, and Supplier Shares by Test

  • $ 750
  • Industry report
  • May 2015

This report provides an overview of the US molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.Table of ContentsBusiness Environment  ...

  • Industries : Pathology, Diagnostics, Healthcare, Medical Biotechnology
  • Countries : United States
3D Cell Culture Market, 2015 - 2025

3D Cell Culture Market, 2015 - 2025

  • $ 2199
  • Industry report
  • May 2015

INTRODUCTIONThe concept of growing tissues outside their natural system in an artificially created microenvironment is known as tissue culturing. It is a common tool for developing model systems that are ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical, Pharmaceutical
  • Countries : United States
Regenerative Medicines: Bone and Joint Applications

Regenerative Medicines: Bone and Joint Applications

  • $ 2750
  • Industry report
  • May 2015

This BCC Research report focuses on the bone- and joint-related applications of and markets for the various categories of regenerative medicine products currently available and projected to be introduced ...

  • Industries : Medical Biotechnology
  • Countries : United States
Global Market Study on Biopharmaceuticals: Asia to Witness Highest Growth by 2020

Global Market Study on Biopharmaceuticals: Asia to Witness Highest Growth by 2020

  • $ 4900
  • Industry report
  • May 2015

Biopharmaceuticals are medicinal drugs which are produced through biotechnology methods such as recombinant DNA techniques, fermentation, hybridoma techniques, and purification processes. Biopharmaceutical ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical
  • Countries : United States
2015 Strategies in the US Nucleic Acid Testing Market

2015 Strategies in the US Nucleic Acid Testing Market

  • $ 6200
  • Industry report
  • May 2015

Highlights Comprehensive 1,157-page Market Segmentation Analysis of the US NAT market. Major issues pertaining to the US NAT laboratory practice, as well as key economic, regulatory, demographic, social ...

  • Industries : Pathology
  • Countries : United States
Proteomics Research Markets

Proteomics Research Markets

  • $ 4200
  • Industry report
  • May 2015

Proteomics Research Markets examines proteomics research processes in detail and in terms of their instrument and technological requirements relating to mass spectrometry, liquid chromatography and electrophoresis. ...

  • Industries : Genomics Proteomics and Enabling Technology
  • Countries : United States, World
Congestive Heart Failure - Pipeline Analysis

Congestive Heart Failure - Pipeline Analysis

  • $ 3600
  • Industry report
  • May 2015

“Congestive Heart Failure (CHF) Pipeline Analysis” gives comprehensive insight on the various drugs being developed for the treatment of CHF. The report covers all the drugs being developed in various ...

  • Industries : Therapy, Pharmaceutical, Medical Biotechnology, Biopharmaceutical, Biopharmaceutical, Chronic Disease
  • Countries : United States, World
Chronic Kidney Disease - Pipeline Analysis

Chronic Kidney Disease - Pipeline Analysis

  • $ 3600
  • Industry report
  • May 2015

“Chronic Kidney Disease (CKD) Pipeline Analysis” gives comprehensive insight on the various drugs being developed for the treatment of CKD. The report covers all the drugs being developed in various ...

  • Industries : Chronic Disease, Therapy, Medical Biotechnology, Biopharmaceutical, Biopharmaceutical, Pharmaceutical, Pathology
  • Countries : World, United States
Physician Views: Anti-CGRP mAbs looking to shake up migraine prevention – how and where will they fit in?

Physician Views: Anti-CGRP mAbs looking to shake up migraine prevention – how and where will they fit in?

  • $ 781
  • Industry report
  • May 2015

Drugmakers may finally have cracked the code to developing safe and effective inhibitors of the calcitonin gene-related peptide (CGRP), a neuropeptide long believed to be associated with migraine headaches ...

  • Industries : Therapy, Medical Biotechnology, Pharmaceutical, OTC, Health Services
  • Countries : United States
Inflammatory bowel disease (Crohn%s) & Ulcerative Colitis

Inflammatory bowel disease (Crohn%s) & Ulcerative Colitis

  • $ 5000
  • Industry report
  • May 2015

Datamonitor Healthcare forecasts strong growth in the IBD market during 2014–23, driven by the lucrative US market, with the impact of new product launches expected to outweigh downward pressure from ...

  • Industries : Pathology, Healthcare
  • Countries : United States, Japan, North America, European Union, East Asia, Europe
Global Biopharmaceuticals Industry

Global Biopharmaceuticals Industry

  • $ 4950
  • Industry report
  • May 2015

This report analyzes the worldwide markets for Biopharmaceuticals in US$ Million by the following Segments: Recombinant Protein, Monoclonal Antibodies (mAbs), Insulin, and Vaccines. The report provides ...

  • Industries : Medical Biotechnology
  • Countries : APAC, World, Europe, United States, Japan, Canada, North America
The Market for Prenatal, Newborn and Carrier Genetic Testing

The Market for Prenatal, Newborn and Carrier Genetic Testing

  • $ 4200
  • Industry report
  • May 2015

The Market for Prenatal, Newborn and Carrier Genetic Testing provides the world markets for prenatal, newborn, postnatal, and carrier genetic testing for 2014 to 2019. In addition, company revenues are ...

  • Industries : Pathology, Diagnostics, Biotechnology, Healthcare, Genomics Proteomics and Enabling Technology
  • Countries : United States
U.S. Markets for Orthopedic Biologic and Tissue Engineered Products

U.S. Markets for Orthopedic Biologic and Tissue Engineered Products

  • $ 4750
  • Industry report
  • May 2015

Biologics and cellular therapies for musculoskeletal injuries—including hard tissue (i.e., bone) and soft tissue (i.e., cartilage, ligaments, and tendons)—represent a billion dollar market that is ...

  • Industries : Medical Biotechnology, Pharmaceutical
  • Countries : United States
North American Nerve Repair & Regeneration Market by Type, by Procedure -Forecast to 2019

North American Nerve Repair & Regeneration Market by Type, by Procedure -Forecast to 2019

  • $ 2603
  • Industry report
  • April 2015

The nerve repair and regeneration market in North America is projected to grow at a strong rate—a CAGR of 11.4 %. The U.S. held the maximum market share, followed by Canada and Mexico. By product, the ...

  • Industries : Security Systems
  • Countries : North America, United States
Physician Views: What scope for the next oral RA therapy?

Physician Views: What scope for the next oral RA therapy?

  • $ 781
  • Industry report
  • April 2015

The rheumatoid arthritis (RA) market is one of the largest in the pharmaceutical sector and is dominated by biologic therapies, primarily the TNF inhibitors. The three largest products in this category ...

  • Industries : Medical Biotechnology
  • Countries : United States, Europe
12th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production

12th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production

  • $ 1632
  • Industry report
  • April 2015

Description: The 2015 12th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production is the most recent study of biotherapeutic developers and contract manufacturing organizations' ...

  • Industries : Medical Biotechnology
  • Countries : United States
Physician Views: CMS guidance on biosimilar reimbursement – what do oncologists and rheumatologists think?

Physician Views: CMS guidance on biosimilar reimbursement – what do oncologists and rheumatologists think?

  • $ 781
  • Industry report
  • April 2015

Recent FDA approval of the first US biosimilar product has spurred the Centers for Medicare and Medicaid Services (CMS) to publish new guidance relating to biosimilar reimbursement and usage (ViewPoints: ...

  • Industries : Medical Biotechnology
  • Countries : United States
Library Preparation and Target Enrichment for Next Generation Sequencing Product Markets

Library Preparation and Target Enrichment for Next Generation Sequencing Product Markets

  • $ 3995
  • Industry report
  • March 2015

Library Preparation and Target Enrichment technologies are a necessary part of the sequencer's use in clinical applications. As the sequencer technologies become cheaper, they have been increasingly moving ...

  • Industries : Genomics Proteomics and Enabling Technology, Biotechnology
  • Countries : United States
Human Growth Hormone Market in the US 2015-2019

Human Growth Hormone Market in the US 2015-2019

  • $ 2500
  • Industry report
  • March 2015

About Human Growth HormoneHuman growth hormone, also known as somatotropin, is a peptide with 191 amino acids and 2 sulfhydryl bridges. It is produced by the anterior pituitary, and it is required to attain ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical, Pharmaceutical
  • Countries : United States
Physician Views: How comfortable are doctors with the commercial use of gene therapy?

Physician Views: How comfortable are doctors with the commercial use of gene therapy?

  • $ 781
  • Industry report
  • March 2015

Gene therapy has been around for decades, yet in a sense the concept has recently been made to feel new again thanks to some notable breakthroughs and milestones, not least of which was the European marketing ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical
  • Countries : Europe, United States
Physician Views: Oncologists react to approval of Zarxio – the first US biosimilar

Physician Views: Oncologists react to approval of Zarxio – the first US biosimilar

  • $ 781
  • Industry report
  • March 2015

Following unanimous recommendation from the FDA's Oncologic Drugs Advisory Committee (ODAC) in mid-January, FDA approval for Novartis' Zarxio – announced on Friday – came as little surprise (ViewPoints: ...

  • Industries : Medical Biotechnology
  • Countries : United States
The Evolving Landscape in Biosimilars

The Evolving Landscape in Biosimilars

  • $ 4500
  • Industry report
  • March 2015

The outlook for biosimilars has changed dramatically over the last five years, due to product development progress, regulatory guidance, and new company strategies Biosimilars have now moved well past ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical, Pharmaceutical
  • Countries : United States
Analysis of Genentech, Inc.

Analysis of Genentech, Inc.

  • $ 300
  • Company report
  • March 2015

Genentech, Inc., an independent subsidiary of Roche Holding, is a leading biotech company headquartered in California, United States. The company's primary focus is on developing drugs for medical conditions ...

  • Industries : Therapy
  • Countries : United States
FirstView Barriers – An Analysis of Market Barriers in Multiple Sclerosis (US)

FirstView Barriers – An Analysis of Market Barriers in Multiple Sclerosis (US)

  • $ 5586
  • Industry report
  • March 2015

FirstView Barriers – An Analysis of Market Barriers in Multiple Sclerosis (EU5) provides cutting edge, advanced and proprietary analytics that companies operating in the MS space need to develop, shape ...

  • Industries : Medical Biotechnology
  • Countries : United States
Analysis of Agenus Inc

Analysis of Agenus Inc

  • $ 300
  • Industry report
  • March 2015

Agenus Inc. is a pharmaceutical manufacturing company that is involved in the development of a portfolio of checkpoint modulators (CPMs), heat shock protein peptide-based vaccines and adjuvants for the ...

  • Industries : Therapy
  • Countries : United States
FirstView Barriers – An Analysis of Market Barriers in Multiple Sclerosis (EU5)

FirstView Barriers – An Analysis of Market Barriers in Multiple Sclerosis (EU5)

  • $ 5586
  • Industry report
  • March 2015

FirstView Barriers – An Analysis of Market Barriers in Multiple Sclerosis (US) provides cutting edge, advanced and proprietary analytics that companies operating in the MS space need to develop, shape ...

  • Industries : Medical Biotechnology
  • Countries : United States, France, Germany, Italy, Spain, United Kingdom
U.S. Markets for Biologic and Tissue Engineered Devices – Cardiovascular and Neurological Products

U.S. Markets for Biologic and Tissue Engineered Devices – Cardiovascular and Neurological Products

  • $ 3750
  • Industry report
  • March 2015

Tissue engineering, or regenerative medicine, represents a promising therapeutic possibility for the treatment of aggressive and deadly diseases. Cellular therapies for cardiovascular disease (CVD) and ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical, Pathology, Pharmaceutical
  • Countries : United States, North America
Analysis of Amgen Inc.

Analysis of Amgen Inc.

  • $ 300
  • Company report
  • March 2015

Amgen Inc., a biotechnology medicines company, discovers, develops, manufactures, and delivers human therapeutics based on advances in cellular and molecular biology primarily in the United States, Europe, ...

  • Industries : Therapy
  • Countries : United States
Physician Views – Sanofi secures US Toujeo approval, but are endocrinologists convinced?

Physician Views – Sanofi secures US Toujeo approval, but are endocrinologists convinced?

  • $ 781
  • Industry report
  • February 2015

As expected, Sanofi's incoming CEO will have a shiny new product franchise to launch when he takes the helm in April. The French company confirmed on Wednesday that Toujeo – a more potent version of ...

  • Industries : Medical Biotechnology
  • Countries : United States
Contract Manufacturing in Pharmaceutical Industry, 2015 - 2025

Contract Manufacturing in Pharmaceutical Industry, 2015 - 2025

  • $ 2199
  • Industry report
  • February 2015

INTRODUCTIONAmongst the increasing financial pressures and the need to reduce cost and improve efficiencies, the pharmaceutical industry has witnessed a paradigm shift from vertically integrated business ...

  • Industries : Pharmaceutical, Medical Biotechnology, Biopharmaceutical, Biopharmaceutical
  • Countries : United States, North America

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on